|
|
|
|
|||||
|
|
|
RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
[email protected]
Media Contact:
Alyssa Horowitz
[email protected]
| Sep-04 | |
| Sep-02 | |
| Aug-07 | |
| Aug-06 | |
| Aug-06 | |
| Aug-04 | |
| Jul-31 | |
| Jul-31 | |
| Jul-30 | |
| Jul-29 | |
| Jul-18 | |
| Jul-15 | |
| Jul-11 | |
| Jul-10 | |
| Jul-09 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite